These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38262580)

  • 21. MYB RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish Breast Adenoid Cystic Carcinoma From Other Triple-negative Breast Carcinomas.
    Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
    Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A pilot study: Comparison of TRPS1 and GATA3 immunoperoxidase staining using cytologic smears in entities reportedly positive for GATA3.
    Rohra P; Ding C; Yoon EC; Gan Q
    Cancer Cytopathol; 2022 Dec; 130(12):930-938. PubMed ID: 35790088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE-A and NY-ESO-1 expression in adenoid cystic carcinoma.
    Beppu S; Ito Y; Fujii K; Saida K; Takino H; Masaki A; Murase T; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Ijichi K; Murakami S; Inagaki H
    Histopathology; 2017 Aug; 71(2):305-315. PubMed ID: 28370175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential.
    Foschini MP; Krausz T
    Semin Diagn Pathol; 2010 Feb; 27(1):77-90. PubMed ID: 20306833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma.
    Baba S; Akashi T; Kayamori K; Ohuchi T; Ogawa I; Kubota N; Nakano K; Nagatsuka H; Hasegawa H; Matsuzaka K; Tomii S; Uchida K; Katsuta N; Sekiya T; Ando N; Miura K; Ishibashi H; Ariizumi Y; Asakage T; Michi Y; Harada H; Sakamoto K; Eishi Y; Okubo K; Ikeda T
    Pathol Int; 2021 Feb; 71(2):113-123. PubMed ID: 33333616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
    Parkinson B; Chen W; Shen T; Parwani AV; Li Z
    Am J Surg Pathol; 2022 Mar; 46(3):415-423. PubMed ID: 35175968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas).
    Marchiò C; Weigelt B; Reis-Filho JS
    J Clin Pathol; 2010 Mar; 63(3):220-8. PubMed ID: 20203221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin.
    Almási S; Kuthi L; Sejben A; Vörös A; Nagy Á; Zombori T; Cserni G
    Virchows Arch; 2023 May; 482(5):861-868. PubMed ID: 37012444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoid cystic carcinomas of the salivary gland, lacrimal gland, and breast are morphologically and genetically similar but have distinct microRNA expression profiles.
    Andreasen S; Tan Q; Agander TK; Steiner P; Bjørndal K; Høgdall E; Larsen SR; Erentaite D; Olsen CH; Ulhøi BP; von Holstein SL; Wessel I; Heegaard S; Homøe P
    Mod Pathol; 2018 Aug; 31(8):1211-1225. PubMed ID: 29467480
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TRPS1 is a promising marker for all subtypes of breast cancer.
    Lui JW; Tsang JY; Li J; Ko CW; Tam F; Loong TC; Tse GM
    Histopathology; 2024 Apr; 84(5):822-836. PubMed ID: 38173281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MYB Translocation Status in Salivary Gland Epithelial-Myoepithelial Carcinoma: Evaluation of Classic, Variant, and Hybrid Forms.
    Bishop JA; Westra WH
    Am J Surg Pathol; 2018 Mar; 42(3):319-325. PubMed ID: 29135517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancers.
    Wetterskog D; Lopez-Garcia MA; Lambros MB; A'Hern R; Geyer FC; Milanezi F; Cabral MC; Natrajan R; Gauthier A; Shiu KK; Orr N; Shousha S; Gatalica Z; Mackay A; Palacios J; Reis-Filho JS; Weigelt B
    J Pathol; 2012 Jan; 226(1):84-96. PubMed ID: 22015727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features.
    Schwartz CJ; Brogi E; Marra A; Da Cruz Paula AF; Nanjangud GJ; da Silva EM; Patil S; Shah S; Ventura K; Razavi P; Norton L; D'alfonso T; Weigelt B; Pareja F; Reis-Filho JS; Wen HY
    Mod Pathol; 2022 Feb; 35(2):193-201. PubMed ID: 34599282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPS1 expression in primary and metastatic prostatic adenocarcinoma, muscle invasive bladder urothelial carcinoma, and breast carcinoma: Is TRPS1 truly specific and sensitive for a breast primary?
    Bachert SE; Di J; Zhang S; Short HE; Piecoro DW; McDonald RJ; Myint ZW; Hensley PJ; Allison DB
    Hum Pathol; 2024 Jan; 143():42-49. PubMed ID: 38052269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
    Reyes C; Jorda M; Gomez-Fernández C
    Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.
    Schwarz S; Müller M; Ettl T; Stockmann P; Zenk J; Agaimy A
    Int J Clin Exp Pathol; 2011 Apr; 4(4):336-48. PubMed ID: 21577319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary gland-like breast carcinomas: An infrequent disease.
    Sherwell-Cabello S; Maffuz-Aziz A; Ríos-Luna NP; Bautista-Piña V; Rodríguez-Cuevas S
    Pathol Res Pract; 2016 Nov; 212(11):1034-1038. PubMed ID: 27667558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.
    Cima L; Kaya H; Marchiò C; Nishimura R; Wen HY; Fabbri VP; Foschini MP
    Virchows Arch; 2022 Jan; 480(1):109-126. PubMed ID: 34458945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.